Dov Elefant is CFO at Cellectar Biosciences, Inc. (CLRB). They have made 3 open-market trades across 2 companies since 2020, most recently 2026-08-07.
CIK 0001326487
3 open-market purchases totalling $65K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FEMY | 15,625 | $27K |
| CLRB | 11,755 | $13K |
| Total | $41K |
Shares reported on the most recent Form 4, priced at the 2026-08-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.